Literature DB >> 976329

The dependence of the blood level of the oxime HS-6 on the severity of organophosphate poisoning.

O L Wolthuis, H J Clason-Van Der Wiel, R Visser.   

Abstract

Atropinised anaesthetised rats were injected i.v. with 4, 6 or 8 X LD50 of the organophosphorous anticholinesterase soman. Subsequent treatment with one dose of HS-6 (100 mg/kg, i.v.) delayed respiratory failure by 1 h or more; a further postponement was obtained when an additional HS-6 infusion was given. At the same infusion rate, HS-6 blood levels after 4 X LD50 soman remained stationary, but rose after the higher soman doses. The rise was greater the higher the soman dose had been. This rapid rise in oxime blood levels after high doses of organophosphate may seriously complicate therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976329     DOI: 10.1016/0014-2999(76)90155-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Pharmacokinetics of pralidoxime chloride. A comparative study in healthy volunteers and in organophosphorus poisoning.

Authors:  D Jovanović
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro.

Authors:  J E Tattersall
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Reversible and irreversible inhibition of rat brain muscarinic receptors is related to different substitutions on bisquaternary pyridinium oximes.

Authors:  Y Kloog; R Galron; D Balderman; M Sokolovsky
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

4.  Plasma concentrations of pralidoxime methylsulphate in organophosphorus poisoned patients.

Authors:  J L Willems; J P Langenberg; A G Verstraete; M De Loose; B Vanhaesebroeck; G Goethals; F M Belpaire; W A Buylaert; D Vogelaers; F Colardyn
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

5.  The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.

Authors:  B Bosković
Journal:  Arch Toxicol       Date:  1979-07-11       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.